Evidence map›Paper›PMID 38068943›Full record

ArticleInternational journal of molecular sciences2023

Comparison of Steroidogenic and Ovulation-Inducing Effects of Orthosteric and Allosteric Agonists of Luteinizing Hormone/Chorionic Gonadotropin Receptor in Immature Female Rats.

Kira V Derkach, Ivan A Lebedev, Irina Yu Morina, Andrey A Bakhtyukov, Alena S Pechalnova, Viktor N Sorokoumov, Veronica S Kuznetsova, Irina V Romanova, Alexander O Shpakov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kira V DerkachSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0001-6555-9540
Ivan A LebedevSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.
Irina Yu MorinaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0002-2252-0088
Andrey A BakhtyukovSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0002-2060-2020
Alena S PechalnovaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0009-0002-4240-4604
Viktor N SorokoumovSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0002-4917-2175
Veronica S KuznetsovaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0009-0003-0668-2110
Irina V RomanovaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0002-0348-0631
Alexander O ShpakovSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.ORCID 0000-0002-4293-3162
Institute of Evolutionary Physiology and Biochemistry · RU

Funding

Russian Science Foundation 19-75-20122
6 · The paper itself

Abstract

Gonadotropins, including human chorionic gonadotropin (hCG), are used to induce ovulation, but they have a number of side effects, including ovarian hyperstimulation syndrome (OHSS). A possible alternative is allosteric luteinizing hormone (LH)/hCG receptor agonists, including the compound TP4/2 we developed, which remains active when administered orally. The aim was to study the effectiveness of TP4/2 (orally, 40 mg/kg) as an ovulation inducer in FSH-stimulated immature female rats, compared with hCG (s.c., 15 IU/rat). TP4/2 stimulated progesterone production and corpus luteum formation; time-dependently increased the ovarian expression of steroidogenic genes (

Indexed as

Luteinizing HormoneOvarian Hyperstimulation SyndromeAnimalsChorionic GonadotropinFemaleGonadal Steroid HormonesHumansOvulationRatsReceptors, LHVascular Endothelial Growth Factor AChorionic GonadotropinGonadal Steroid HormonesLuteinizing HormoneReceptors, LHVascular Endothelial Growth Factor Aallosteric agonistchorionic gonadotropinimmature female ratluteinizing hormone receptormetalloproteinase ADAMTS-1ovarian steroidogenesisovulationvascular endothelial growth factor

Identifiers

PMID38068943
PMCPMC10706028
OpenAlexW4388913042

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.